The ACTA2 Gene Moyamoya Disease Type 5 NGS Genetic DNA Test is essential for diagnosing Moyamoya disease, a rare cerebrovascular disorder.this test helps identify genetic predispositions, enabling timely intervention and management. The test is performed using advanced NGS technology and is crucial for patients with a family history of vascular issues.
- Call Anytime: +254 704 150555
- info@biopassiondiagnostics.co.ke
ACTA2 Gene Moyamoya Disease Type 5 Genetic Test
Genetic Testing
ACTA2 Gene Moyamoya Disease Type 5 Genetic Test
KSh 56,000.00
Regular price
KSh 47,600.00
Current price
-15%
What Is the ACTA2 Gene Moyamoya Disease Type 5 Genetic Test?
The ACTA2 Gene Moyamoya Disease Type 5 NGS Genetic DNA Test is a cutting-edge genetic test that plays a crucial role in diagnosing Moyamoya disease, a rare and progressive cerebrovascular disorder characterized by stenosis or occlusion of the internal carotid arteries and their major branches. This disorder can lead to significant neurological deficits, including strokes, transient ischemic attacks, and cognitive impairment. Early diagnosis through genetic testing is vital for effective management and intervention.
Who Should Consider This Test?
The ACTA2 Gene Moyamoya Disease Type 5 NGS Genetic DNA Test is recommended for individuals who exhibit the following:
- Symptoms of cerebrovascular disorders, such as headaches, seizures, or transient ischemic attacks.
- A family history of Moyamoya disease or related vascular conditions.
- Neurological symptoms without a clear cause.
What Does the Test Detect or Measure?
This genetic test specifically detects mutations in the ACTA2 gene, which have been associated with Moyamoya disease. By analyzing the genetic material from a blood sample, the test identifies any pathogenic variants that may contribute to the development of this condition.
What the Results May Show
Upon completion of the test, results will be analyzed and interpreted by genetic specialists. A positive result indicates the presence of a mutation in the ACTA2 gene linked to Moyamoya disease, while a negative result suggests no identified genetic predisposition. It is essential to discuss the results with a healthcare provider for appropriate guidance and management options.
Benefits or Clinical Value
Undergoing the ACTA2 Gene Moyamoya Disease Type 5 NGS Genetic DNA Test offers several benefits:
- Early detection of genetic predispositions allows for timely intervention.
- Informs treatment options and management strategies for affected individuals.
- Provides valuable information for family planning and genetic counseling.
Pricing
| Test Name | Current Price | Regular Price |
|---|---|---|
| ACTA2 Gene Moyamoya Disease Type 5 Genetic Test | KSh 47,600.00 | KSh 56,000.00 |
Book the ACTA2 Gene Moyamoya Disease Type 5 Genetic Test
Contact Biopassion Diagnostics to confirm sample requirements and schedule this test.
SKU: 812214fb8e70 | Category: Genetic Testing